After Slow Start, St. Jude Says Portico TAVI Is Primed To Gain Traction
This article was originally published in The Gray Sheet
Executive Summary
St. Jude Medical’s Portico transcatheter aortic valve is poised to become more competitive in Europe in 2014 as more sizes become available, executives told investors during the firm’s Feb. 7 annual investor conference. And the firm is talking to FDA about alternative pivotal trial designs.